Bio,  Felicis Ventures,  Ginkgo Bioworks,  OS Fund,  sam altman,  TC,  Venture Capital,  Viking Global,  Y Combinator,  Zymergen

Ginkgo Bioworks Takes On Zymergen With $45 Million In Series B Funding

Ginkgo Bioworks Boston biotech startup Ginkgo Bioworks just gained an extra $45 million in Series B funding from an “oversubscribed” list of investors. The startup raised $9 million in March, so that gives the startup $54 million in total funding thus far. Biotech startups went from far and few to red hot in the last couple of years, thanks to new techniques, automated robots, lowered… Read More